Meredith A. Fox, Ph.D. - Publications

Affiliations: 
2003 American University, Washington, DC, United States 
Area:
Behavioral Pharmacology

20 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Ramadan E, Blanchard H, Cheon Y, Fox MA, Chang L, Chen M, Ma K, Rapoport SI, Basselin M. Transient postnatal fluoxetine leads to decreased brain arachidonic acid metabolism and cytochrome P450 4A in adult mice. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 90: 191-7. PMID 24529827 DOI: 10.1016/j.plefa.2014.01.003  0.96
2013 Haberzettl R, Bert B, Fink H, Fox MA. Animal models of the serotonin syndrome: a systematic review. Behavioural Brain Research. 256: 328-45. PMID 24004848 DOI: 10.1016/j.bbr.2013.08.045  0.96
2013 Stevenson GW, Fox MA. The neuropharmacology of the age-old sedative/hypnotic, ethanol. Frontiers in Neuroscience. 7: 122. PMID 23874266 DOI: 10.3389/fnins.2013.00122  0.96
2013 Murphy DL, Moya PR, Fox MA, Rubenstein LM, Wendland JR, Timpano KR. Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive-compulsive disorder as an example of overlapping clinical and genetic heterogeneity. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 368: 20120435. PMID 23440468 DOI: 10.1098/rstb.2012.0435  0.96
2013 Fox MA, Panessiti MG, Hall FS, Uhl GR, Murphy DL. An evaluation of the serotonin system and perseverative, compulsive, stereotypical, and hyperactive behaviors in dopamine transporter (DAT) knockout mice. Psychopharmacology. 227: 685-95. PMID 23417514 DOI: 10.1007/s00213-013-2988-x  0.96
2013 Fox MA, Panessiti MG, Moya PR, Tolliver TJ, Chen K, Shih JC, Murphy DL. Mutations in monoamine oxidase (MAO) genes in mice lead to hypersensitivity to serotonin-enhancing drugs: implications for drug side effects in humans. The Pharmacogenomics Journal. 13: 551-7. PMID 22964922 DOI: 10.1038/tpj.2012.35  0.96
2011 Moya PR, Fox MA, Jensen CL, Laporte JL, French HT, Wendland JR, Murphy DL. Altered 5-HT2C receptor agonist-induced responses and 5-HT2C receptor RNA editing in the amygdala of serotonin transporter knockout mice. Bmc Pharmacology. 11: 3. PMID 21473759 DOI: 10.1186/1471-2210-11-3  0.96
2010 Fox MA, Stein AR, French HT, Murphy DL. Functional interactions between 5-HT2A and presynaptic 5-HT1A receptor-based responses in mice genetically deficient in the serotonin 5-HT transporter (SERT). British Journal of Pharmacology. 159: 879-87. PMID 20128812 DOI: 10.1111/j.1476-5381.2009.00578.x  0.96
2010 Fox MA, French HT, LaPorte JL, Blackler AR, Murphy DL. The serotonin 5-HT(2A) receptor agonist TCB-2: a behavioral and neurophysiological analysis. Psychopharmacology. 212: 13-23. PMID 19823806 DOI: 10.1007/s00213-009-1694-1  0.96
2009 Fox MA, Jensen CL, Murphy DL. Tramadol and another atypical opioid meperidine have exaggerated serotonin syndrome behavioural effects, but decreased analgesic effects, in genetically deficient serotonin transporter (SERT) mice. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 12: 1055-65. PMID 19275775 DOI: 10.1017/S146114570900011X  0.96
2009 Basselin M, Fox MA, Chang L, Bell JM, Greenstein D, Chen M, Murphy DL, Rapoport SI. Imaging elevated brain arachidonic acid signaling in unanesthetized serotonin transporter (5-HTT)-deficient mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 1695-709. PMID 19145225 DOI: 10.1038/npp.2008.227  0.96
2008 Murphy DL, Fox MA, Timpano KR, Moya PR, Ren-Patterson R, Andrews AM, Holmes A, Lesch KP, Wendland JR. How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems. Neuropharmacology. 55: 932-60. PMID 18824000 DOI: 10.1016/j.neuropharm.2008.08.034  0.96
2008 Fox MA, Jensen CL, French HT, Stein AR, Huang SJ, Tolliver TJ, Murphy DL. Neurochemical, behavioral, and physiological effects of pharmacologically enhanced serotonin levels in serotonin transporter (SERT)-deficient mice. Psychopharmacology. 201: 203-18. PMID 18712364 DOI: 10.1007/s00213-008-1268-7  0.96
2007 Fox MA, Jensen CL, Gallagher PS, Murphy DL. Receptor mediation of exaggerated responses to serotonin-enhancing drugs in serotonin transporter (SERT)-deficient mice. Neuropharmacology. 53: 643-56. PMID 17765930 DOI: 10.1016/j.neuropharm.2007.07.009  0.96
2007 Fox MA, Andrews AM, Wendland JR, Lesch KP, Holmes A, Murphy DL. A pharmacological analysis of mice with a targeted disruption of the serotonin transporter. Psychopharmacology. 195: 147-66. PMID 17712549 DOI: 10.1007/s00213-007-0910-0  0.96
2007 Kalueff AV, Fox MA, Gallagher PS, Murphy DL. Hypolocomotion, anxiety and serotonin syndrome-like behavior contribute to the complex phenotype of serotonin transporter knockout mice. Genes, Brain, and Behavior. 6: 389-400. PMID 16939636 DOI: 10.1111/j.1601-183X.2006.00270.x  0.96
2006 Fox MA, Stevenson GW, Rice KC, Riley AL. Naloxone, not proglumide or MK-801, alters effects of morphine preexposure on morphine-induced taste aversions. Pharmacology, Biochemistry, and Behavior. 84: 169-77. PMID 16777201 DOI: 10.1016/j.pbb.2006.05.003  0.96
2003 Fox MA, Chen RS, Holmes CS. Gender differences in memory and learning in children with insulin-dependent diabetes mellitus (IDDM) over a 4-year follow-up interval. Journal of Pediatric Psychology. 28: 569-78. PMID 14602847 DOI: 10.1093/jpepsy/jsg047  0.96
2001 Fox MA, Levine ES, Riley AL. The inability of CCK to block (or CCK antagonists to substitute for) the stimulus effects of chlordiazepoxide. Pharmacology, Biochemistry, and Behavior. 69: 77-84. PMID 11420071 DOI: 10.1016/S0091-3057(01)00505-6  0.96
1999 Holmes CS, Fox MA, Cant MC, Lampert NL, Greer T. Disease and demographic risk factors for disrupted cognitive functioning in children with Insulin-Dependent Diabetes Mellitus (IDDM) School Psychology Review. 28: 215-227.  0.96
Show low-probability matches.